Buscar en
Medicina Clínica (English Edition)
Toda la web
Inicio Medicina Clínica (English Edition) Acute lymphoblastic leukemia of T progenitors: From biology to clinics
Journal Information
Vol. 144. Issue 5.
Pages 223-229 (March 2015)
Download PDF
More article options
Vol. 144. Issue 5.
Pages 223-229 (March 2015)
DOI: 10.1016/j.medcle.2015.05.033
Acute lymphoblastic leukemia of T progenitors: From biology to clinics
Leucemia aguda linfoblástica de precursores T: de la biología a la clínica
Eulàlia Genescàa,
Corresponding author

Corresponding author.
, Jordi Riberaa, Josep-Maria Riberaa,b
a Grupo de Investigación en LAL, Instituto de Investigación contra la Leucemia Josep Carreras (IJC), Badalona, Barcelona, Spain
b Servicio de Hematología Clínica, Instituto Catalán de Oncología (ICO)-Hospital Germans Trias i Pujol (HGTP), Universidad Autónoma de Barcelona (UAB), Badalona, Barcelona, Spain
Article information
Full Text
Download PDF
Tables (3)
Table 1. Main recurrent chromosomal lesions in T-cell acute lymphoblastic leukemia that define molecular subgroups.
Table 2. Other genes recurrently altered in T-cell acute lymphoblastic leukemia.
Table 3. Main prognosis-indicating biomarkers in the T-cell acute lymphoblastic leukemia.
Show moreShow less

Acute lymphoblastic leukemia (ALL) is the most common cancer in children and the main cause of morbidity among childhood blood disorders. There are 2 subtypes according to the affected lymphoid progenitor: B-ALL and T-ALL. The T-ALL is the less common and, although historically was associated with poor prognosis in both adults and children, at present, treatment outcomes do not differ significantly between the 2 types of ALL. The T-ALL subtype is the most complex and heterogeneous at the genetic level and currently the one with less new therapeutic alternatives available. This trend is changing thanks to the remarkable progress upon understanding its biology. This review summarises the most recent and important biological findings in T-ALL and their possible therapeutic implications.

Acute T-cell lymphoblastic leukemia
Molecular markers

La leucemia aguda linfoblástica (LAL) es la neoplasia más frecuente en niños y la principal causa de morbilidad entre las alteraciones hemáticas infantiles. Existen 2 subtipos, según el progenitor linfoide afectado: LAL-B y LAL-T. La LAL-T es menos frecuente e históricamente se asociaba a mal pronóstico tanto en adultos como en niños, aunque en la actualidad los resultados del tratamiento no difieren significativamente entre ambos tipos de LAL. La LAL-T es el subtipo más complejo y heterogéneo a nivel genético y el que menos alternativas terapéuticas nuevas presenta en el momento actual. Esta tendencia está cambiando merced a los progresos notables que se están efectuando en el conocimiento de su biología. En esta revisión se resumen los hallazgos biológicos más importantes en la LAL-T efectuados en los últimos años y sus posibles implicaciones terapéuticas.

Palabras clave:
Leucemia aguda linfoblástica T
Marcadores moleculares


These are the options to access the full texts of the publication Medicina Clínica (English Edition)

If you already have your login data, please click here .

If you have forgotten your password you can you can recover it by clicking here and selecting the option “I have forgotten my password”
Subscribe to

Medicina Clínica (English Edition)

Purchase article

Purchasing article the PDF version will be downloaded

Price 19.34 €

Purchase now
Phone for subscriptions and reporting of errors
From Monday to Friday from 9 a.m. to 6 p.m. (GMT + 1) except for the months of July and August which will be from 9 a.m. to 3 p.m.
Calls from Spain
932 415 960
Calls from outside Spain
+34 932 415 960
Article options
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos